Literature DB >> 16863845

Current outcome of antenatally diagnosed exomphalos: an 11 year review.

Lorin Lakasing1, Simona Cicero, Mark Davenport, Shailesh Patel, Kypros H Nicolaides.   

Abstract

PURPOSE: The aim of this study was to determine the outcome of antenatally diagnosed exomphalos.
METHODS: The database of a tertiary referral Fetal Medicine Centre was searched for all cases of antenatally diagnosed exomphalos between January 1991 and December 2002. Patients, general practitioners, and hospitals were contacted for outcome details.
RESULTS: In total, 445 cases of exomphalos were identified. In 250 (56%) cases, the fetal karyotype was abnormal (group A), in 135 (30%) cases, the karyotype was normal (group B), and in 60 (14%) cases, karyotyping was declined (group C). In group A, there were 248 (99%) terminations of pregnancy (TOP) or fetal deaths and 2 live births. In group B, 74 (54%) fetuses had other structural anomalies; 82 (61%) pregnancies resulted in TOP or fetal death, 42 (31%) in live births, and 11 (8%) were lost to follow-up. In group C, 38 (63%) fetuses had other structural anomalies; 41 (69%) pregnancies resulted in TOP or fetal death, 11 (18%) in live births, and 8 (13%) were lost to follow-up. Of the 55 live births, 11 died preoperatively and 44 had surgery. There were no postoperative deaths.
CONCLUSIONS: Less than 10% of the antenatal diagnostic workload reached operative repair. In our unit, these babies are a highly selected group, which is a factor in the high postoperative survival.

Entities:  

Mesh:

Year:  2006        PMID: 16863845     DOI: 10.1016/j.jpedsurg.2006.04.015

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  11 in total

1.  Perinatal outcome in the live-born infant with prenatally diagnosed omphalocele.

Authors:  Michelle A Kominiarek; Noelia Zork; Sara Michelle Pierce; Terrell Zollinger
Journal:  Am J Perinatol       Date:  2011-05-03       Impact factor: 1.862

2.  Neonatal survival of prenatally diagnosed exomphalos.

Authors:  G Patel; J Sadiq; N Shenker; L Impey; Kokila Lakhoo
Journal:  Pediatr Surg Int       Date:  2009-03-26       Impact factor: 1.827

3.  Gastroschisis and exomphalos in Ireland 1998-2004. Does antenatal diagnosis impact on outcome?

Authors:  F L Murphy; T A Mazlan; F Tarheen; M T Corbally; P Puri
Journal:  Pediatr Surg Int       Date:  2007-08-16       Impact factor: 1.827

Review 4.  Antenatally Diagnosed Surgical Conditions: Fetus As Our Patient.

Authors:  Kashish Khanna; Anjan Kumar Dhua; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2018-07-03       Impact factor: 1.967

Review 5.  Fetal counselling for congenital malformations.

Authors:  Kokila Lakhoo
Journal:  Pediatr Surg Int       Date:  2007-03-14       Impact factor: 2.003

6.  Initial conservative management of exomphalos major with gentian violet.

Authors:  Ashrarur Rahman Mitul; Kmn Ferdous
Journal:  J Neonatal Surg       Date:  2012-10-01

7.  Perinatal mortality in pregnancies with omphalocele: data from the Chinese national birth defects monitoring network, 1996-2006.

Authors:  Kui Deng; Jie Qiu; Li Dai; Ling Yi; Changfei Deng; Yi Mu; Jun Zhu
Journal:  BMC Pediatr       Date:  2014-06-23       Impact factor: 2.125

8.  The validity of the viscero-abdominal disproportion ratio for type of surgical closure in all fetuses with an omphalocele.

Authors:  Nina C J Peters; Annelieke Hijkoop; Rosan L Lechner; Alex J Eggink; Joost van Rosmalen; Dick Tibboel; René M H Wijnen; Hanneke IJsselstijn; Titia E Cohen-Overbeek
Journal:  Prenat Diagn       Date:  2019-08-29       Impact factor: 3.050

9.  Prenatal diagnosis of exomphalos and prediction of outcome.

Authors:  K Nitzsche; G Fitze; M Rüdiger; P Wimberger; C Birdir
Journal:  Sci Rep       Date:  2021-04-22       Impact factor: 4.379

10.  Ductus venosus reversed flow in omphalocele: Could it be a prognostic factor for long-term neurological impairment?

Authors:  Roxana Elena Bohîlțea; Nicolae Bacalbașa; Bianca Margareta Mihai; Corina Grigoriu; Consuela-Mădălina Gheorghe; Tiberiu Augustin Georgescu; Irina Maria Vlădăreanu; Valentin Varlas
Journal:  J Med Life       Date:  2021 Sep-Oct
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.